Optimising neonatal service provision for preterm babies born between 27 and 31 weeks gestation in England (OPTI-PREM), using national data, qualitative research and economic analysis: A study protocol by Pillay, T et al.
1Pillay T, et al. BMJ Open 2019;9:e029421. doi:10.1136/bmjopen-2019-029421
Open access 
Optimising neonatal service provision 
for preterm babies born between 27 and 
31 weeks gestation in England (OPTI-
PREM), using national data, qualitative 
research and economic analysis: a 
study protocol
Thillagavathie Pillay,   1,2 Neena Modi,3 Oliver Rivero-Arias,4 Brad Manktelow,5 
Sarah E Seaton,5 Natalie Armstrong,5 Elizabeth S Draper,5 Kelvin Dawson,6 
Alexis Paton,5 Abdul Qader Tahir Ismail,   1 Miaoqing Yang,4 Elaine M Boyle5
To cite: Pillay T, Modi N, 
Rivero-Arias O, et al.  Optimising 
neonatal service provision for 
preterm babies born between 
27 and 31 weeks gestation in 
England (OPTI-PREM), using 
national data, qualitative 
research and economic analysis: 
a study protocol. BMJ Open 
2019;9:e029421. doi:10.1136/
bmjopen-2019-029421
 ► Additional material for this 
paper are available online. To 
view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2019- 
029421).
Received 04 February 2019
Revised 19 June 2019
Accepted 09 July 2019
For numbered affiliations see 
end of article.
Correspondence to
Dr Thillagavathie Pillay;  
 tilly. pillay@ nhs. net
Protocol
© Author(s) (or their 
employer(s)) 2019. Re-use 
permitted under CC BY. 
Published by BMJ.
AbstrACt
Introduction In England, for babies born at 23–26 weeks 
gestation, care in a neonatal intensive care unit (NICU) as 
opposed to a local neonatal unit (LNU) improves survival 
to discharge. This evidence is shaping neonatal health 
services. In contrast, there is no evidence to guide location 
of care for the next most vulnerable group (born at 27–31 
weeks gestation) whose care is currently spread between 
45 NICU and 84 LNU in England. This group represents 
12% of preterm births in England and over onr-third of 
all neonatal unit care days. Compared with those born at 
23–26 weeks gestation, they account for four times more 
admissions and twice as many National Health Service bed 
days/year.
Methods In this mixed-methods study, our primary 
objective is to assess, for babies born at 27–31 weeks 
gestation and admitted to a neonatal unit in England, 
whether care in an NICU vs an LNU impacts on survival 
and key morbidities (up to age 1 year), at each gestational 
age in weeks. Routinely recorded data extracted from real-
time, point-of-care patient management systems held in 
the National Neonatal Research Database, Hospital Episode 
Statistics and Office for National Statistics, for January 
2014 to December 2018, will be analysed. Secondary 
objectives are to assess (1) whether differences in care 
provided, rather than a focus on LNU/NICU designation, 
drives gestation-specific outcomes, (2) where care is 
most cost-effective and (3) what parents’ and clinicians' 
perspectives are on place of care, and how these could 
guide clinical decision-making. Our findings will be 
used to develop recommendations, in collaboration with 
national bodies, to inform clinical practice, commissioning 
and policy-making. The project is supported by a parent 
advisory panel and a study steering committee.
Ethics and dissemination Research ethics approval 
has been obtained (IRAS 212304). Dissemination will 
be through publication of findings and development of 
recommendations for care.
trial registration number NCT02994849 and 
ISRCTN74230187.
bACkground And rAtIonAlE
Specialised services for babies in England 
are delivered by neonatal units managed 
through Operational Delivery Networks.1 
These are geographical groupings of 
neonatal units working together in care path-
ways, and comprise units that are designated 
as neonatal intensive care units (NICUs), 
local neonatal units (LNUs) and special care 
baby units (SCBUs).2 3 There were 15 opera-
tional delivery networks (ODNs) in England 
in 2018.4 NICUs are located within centres 
that have specialist obstetric and fetoma-
ternal medicine services; they have staff and 
resources to provide tertiary level care for 
babies of all gestational ages with a wide range 
and complexity of conditions. LNUs provide 
care for babies within their local catchment 
strengths and limitations of this study
 ► Scientific evidence from this study will be used to 
develop national recommendations for health ser-
vice delivery for babies born between 27 and 31 
weeks gestation in England.
 ► This will be guided by clinical outcomes, cost-effec-
tiveness, parents’ and staff perspectives.
 ► As a retrospective population-based observational 
cohort study, it is subject to selection bias in the as-
signment of location of birth of babies.
 ► Heterogeneity in the quality of care provided within 
and between local neonatal unit and neonatal inten-
sive care unit, is likely, and will be addressed.
 ► Formal study-driven neurodevelopmental follow-up 
is not cost-effective in this large cohort, so routine-
ly collected data will be used to investigate their 
outcomes.
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area; they are able to provide emergency, short-term 
intensive care but are not resourced to provide long-term 
intensive care. SCBUs provide the lowest intensity of care 
usually for babies born >32 weeks gestation.
Caring for babies born at 23–26 weeks gestation in an 
NICU improves survival to discharge. This is now shaping 
policy for this category of babies.5–7 However, there is no 
evidence to guide the location of care for the next most 
vulnerable group of babies born between 27+0 and 31+6 
weeks gestation (hereafter called ‘born at 27–31 weeks’). 
This is an important group, accounting for around four 
times the throughput in neonatal units compared with 
those born at 23–26 weeks gestation,8 representing ~12% 
of all viable preterm babies born in England in 2013.9
Most ODNs have a defined gestational age cut-off, below 
which they aim to provide care in an NICU.3 10 However, 
these criteria differ between networks and are often not 
adhered to. Currently, care pathways for babies born at 
27–31 weeks gestation are undefined and their manage-
ment is spread, often arbitrarily between NICU and LNU. 
While there is some evidence to suggest that morbidity 
profiles (based on common major morbidities such as 
necrotising enterocolitis, retinopathy of prematurity 
and bronchopulmonary dysplasia) for the total group of 
babies born at 27–31 weeks gestation6 is similar between 
LNU and NICU, it remains unknown whether location 
of care and/or birth, makes a difference to gestation-spe-
cific outcomes. Our research will determine whether the 
type of neonatal unit in the hospital of birth influences 
outcomes for babies born at 27–31 weeks gestation, and 
if so, at which set point within this gestational age range 
care can equitably be provided in either LNU or NICU.
Presently, most pregnant women who want a hospital 
birth are advised to choose antenatal care and delivery in 
a hospital in their area,11 which may have NICU, LNU or 
SCBU facilities. With the advent of Choose and Book,12 
this may be changing. Place of booking may also partly 
be determined by the anticipated degree of illness or 
complexity of care required for either mother or baby, 
if that can be predicted. However, for most women at 
the time of booking for pregnancy care, these risks are 
unknown and unpredictable. Women in threatened 
preterm labour at 27–31 weeks gestation will generally 
attend their hospital of booking for assessment or one 
closest to them at the time. Many will, therefore, deliver 
there, regardless of the type of neonatal care that can 
be offered. Babies that are inevitably born into an SCBU 
setting in this gestational age range are usually trans-
ferred ex-utero to an LNU or NICU for ongoing care. 
They may be returned to an SCBU from an NICU or LNU 
for ‘step-down’ hospital care if this is the unit closest to 
the mother’s home, they are usually older than 32 weeks 
gestation and better, but not yet ready for discharge 
home. Generally, transfers that do occur between hospi-
tals, whether for a mother before delivery or for her baby 
after birth, and are determined by care requirements, 
and by cot capacity and adequacy of neonatal nurse and 
medical staffing.
The total healthcare, social and education costs asso-
ciated to prematurity at 27–31 weeks gestation during 
childhood has been estimated to be £607 million in 
2016.13 Survival in preterm babies has improved in recent 
years, and hospital costs are high. With neonatal intensive 
care averaging £1445 per day and high dependency care 
£925 per day14 in 2017/2018, it is important to ensure 
that care for less sick preterm babies is not unnecessarily 
located within an NICU, and that sicker preterm babies 
are not undersupported in an LNU, potentially resulting 
in prolonged intensive care and greater short-term and 
long-term morbidity. Importantly, if key clinical outcomes 
do not significantly differ between LNU and NICU, 
then cost-effectiveness and family satisfaction should be 
the major drivers for how and where health services are 
delivered.
MEthods And AnAlysIs
objectives of oPtI-PrEM workstreams
OPTI-PREM (Optimising neonatal service provision for 
preterm babies born between 27 and 31 weeks gestation 
in England) is a mixed-methods study comprising five 
workstreams. A summary of the study aims and objectives 
are described in figure 1 and expanded below.
Patient and public involvement
Opti-Prem is supported by a parent advisory panel 
(figure 2) of representatives from BLISS, the acronym 
for the National Charity for babies born preterm or sick. 
The BLISS senior research engagement officer is part of 
the project’s study steering committee. The chair of the 
parent advisory panel is a collaborator on the project.
Workstream 1: Clinical outcomes study
Workstream 1 aims to determine whether the type 
(designation) of unit (NICU vs LNU) at birth influences 
the primary outcome (mortality) and secondary outcomes 
(morbidities) in babies born at 27–31 weeks gestation.
Workstream 2: study of clinical care provided in 
different neonatal units
Variation exists in how neonatal units manage preterm 
babies of all gestational ages, even among units of the 
same designation.15–18 In this workstream, we will address 
the secondary objective of identifying key differences in 
unit characteristics and clinical practices that could influ-
ence outcome. This will allow us to group neonatal units 
based on care provided, and to search for associations 
with gestation specific outcomes, irrespective of their 
designation.
Workstream 3: cost-effectiveness analysis
The health economics analysis investigates whether 
being born in settings with an NICU or LNU represent 
value for money within the National Health Service 
(NHS). A detailed cost analysis of the neonatal care 
received will be carried out. An incremental analysis of 
costs and the number of lives saved between different 
locations of birth will also be conducted.
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Figure 1 Overall aims and objectives for OPTI-PREM. BAPM, British Association of Perinatal Medicine; LNU, local neonatal 
unit; NICU, neonatal intensive care unit; NHS, National Health Service.
Workstream 4: ethnographic study with parents and 
clinicians
Using an ethnographic approach that accesses their 
lived experiences19 20 of caring for these babies, this 
stream explores parents' and clinicians’ experiences 
and perspectives regarding decisions about place of 
care.
Workstream 5: collaboration with the British Associ-
ation of Perinatal Medicine (BAPM) to establish frame-
work documents and recommendations on place of birth.
A working group will be established in collabora-
tion with BAPM, which will engage with relevant stake-
holders, the BLISS parent advisory panel and other 
support groups. Its purpose will be to establish a frame-
work document and design recommendations for 
place of birth for babies born at each week of gestation 
between 27 and 31 weeks, based on the evidence from 
this study.
Workstreams 1 and 3
Population
All babies born at 27–31 weeks gestation between 1 
January 2014 and 31 December 2018, in an English 
hospital with an LNU or NICU, whose records are 
captured within the National Neonatal Research Data-
base (NNRD) will be included. With approximately 6000 
babies per year in England meeting our criteria, the study 
is expected to include data on approximately 30 000 
babies. Data on births and transfers to and from an SCBU 
will also be captured, to provide baseline information of 
place of birth, care and transfer across all neonatal units 
in England for this gestational age range.
Data sources:
1. Neonatal data: The NNRD will provide data on ad-
missions to LNU or NICU in England. The NNRD is 
maintained by the NDAU and created from electron-
ic health records.21 It includes the information on 
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Figure 2 Overview of OPTI-PREM workstreams. BAPM, British Association of Perinatal Medicine; LNU, local neonatal unit; 
NICU, neonatal intensive care unit; NNRD, National Neonatal Research Database; ODNs, operational delivery network;
characteristics of mothers and babies (eg, maternal 
pregnancy information, baby’s birth weight, sex and 
gestational age), admission-related episodes (eg, rea-
son for admission, admission temperature, length of 
stay and the number of episodes of care) and daily 
neonatal care of the babies after birth (eg, treatment, 
clinical procedures and morbidities).
2. Postneonatal data: To assess outcomes (survival and 
morbidities) to 365 days of age, the NNRD data will be 
linked to:
i. Hospital Episode Statistics (HES): information 
all admissions, outpatient appointments and 
accident and emergency attendances at NHS hos-
pitals in England.
ii. Office for National Statistics (ONS): information 
on location, date and cause of death, obtained 
from death registration records.
Neonatal units will be allowed to assess the quality 
of their data entry onto electronic records, based on 
completion of data being fed back to neonatal units for 
surfactant replacement, nitric oxide and discharge home 
on oxygen.
Inclusion and exclusion criteria: Units will be offered 
an opt-out option at the start of the project. The 
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confidentiality of neonatal units who chose to opt out will 
be respected. A minimum dataset describing these units 
will only be reported if it is possible to maintain their 
anonymity in this process.
Clinical outcomes: The primary outcome for work-
stream 1 is death before discharge from a neonatal unit. 
We expect a within-unit mortality percentage of approx-
imately 5% in this group. Information on deaths outside 
of neonatal care will be provided from ONS.
Secondary outcomes (eg, bronchopulmonary dysplasia, 
retinopathy of prematurity requiring laser treatment and 
worst cranial ultrasound abnormalities)22 will be extracted 
from the daily care records in the NNRD. Data will be 
investigated for inconsistencies, out of range values and 
missing observations prior to the analysis of workstream 
1. Special attention will be paid to morbidities that may 
be more relevant to this group of babies, such as growth 
during hospitalisation, blood stream infections, patent 
ductus arteriosus, time to full enteral feeds, time to breast 
feeding at initiation and breast feeding at discharge.
Statistical methods: In the absence of randomised treat-
ment allocation, the difference in mean outcomes of 
babies born in either setting with an NICU or an LNU 
might be biassed if they are different in baseline charac-
teristics, that is, our data sources are subject to selection 
bias. The analysis needs to account for the potential bias 
arising from the non-random allocation of babies to the 
two types of ‘interventions’. We will tackle these issues in 
our analysis using matching and instrumental variables 
(IVs) methods. The same approaches will be followed by 
workstreams 1 and 3.
Matching to account for measured confounding: 
We will use matching to construct a balanced sample 
of babies who were born in NICU or LNU based on 
observed characteristics, assuming that these groups do 
not differ in relevant unobservable characteristics so 
that the differences in outcomes between them may be 
attributed to the location of birth. We will use propen-
sity scores (PS), which are predicted probabilities of the 
relevant observed covariates that would be expected to 
be equal for both groups if the conditional distribution is 
independent of whether the baby is born in an NICU or 
LNU.23 24 To compute the PS, a logistic model for place of 
birth will be fitted (LNU vs NICU). The independent vari-
ables will include a priori decided set of variables on the 
basis of expert and clinician input and/or variables asso-
ciated with the type of unit at the place of birth. Based on 
previous literature25 26 and the data availability in NNRD, 
we will evaluate a relatively large number of covariates for 
this model including: gestational age, birth weight, sex 
of the baby, mothers’ ethnicity, use of antenatal steroids, 
5 min Apgar score, deprivation, temperature at birth, 
maternal medical problems prior to this pregnancy and 
problems encountered during pregnancy. The selected 
variables are expected to influence either the place of 
birth or babies’ outcomes, but none of them would be 
expected to be influenced by whether the baby is born 
in an NICU or LNU as they are defined at baseline prior 
to or immediately after the birth. We believe that the 
model developed in the above steps will produce the PS 
given the observed set of covariates to produce balanced 
groups for the analyses; this means that babies who were 
born in NICUs and those who were born in LNUs with 
equal PS will have the same distributions of the observed 
covariates. After the PS is computed from the model, a 
matched sample will be created and the covariates will be 
compared between the groups in the matched sample to 
examine whether the balance has been achieved or not. 
If the sufficient balance is not achieved, the PS model will 
be modified and balance will be reassessed. We will inves-
tigate the range of estimated PS for both NICU and LNU 
babies to identify the region of common support. If there 
is no comparable NICU baby found in the LNU group, 
the analyses would produce biassed estimates by matching 
LNU babies with NICU babies with different characteris-
tics. Therefore, observations not under common support 
should be dropped from the matching, but we will 
describe the characteristics of these babies in descriptive 
statistics. It is difficult to define the size of this matched 
sample at this stage. The sample size will be affected by 
how relevant it will be considered to the general popula-
tion and will be reviewed by the study team. If required, 
other matching methods will also be applied, such as 
Mahalanobis distance matching and genetic matching.27
IVs to account for unmeasured confounding: Since 
matching is based on the assumption that the place of 
birth is independent of the potential outcomes condi-
tional on the matching variables (also known as measured 
confounding). This requires that variables that affect 
both outcomes and the place of birth are observed and 
controlled in the matching algorithm. In our case, after 
matching the babies who were born in NICU or LNU on 
the basis of observed characteristics, it is possible that 
unobserved confounding variables still remain unbal-
anced between the two groups and the matching would 
result in biassed estimates of the effects of being born in 
NICU compared with LNU. Although we believe that the 
richness of our dataset makes the assumptions behind 
the matching plausible, we will complement our anal-
yses using IVs.28 We will explore two-stage least squared 
regression (2SLS) models with exclusion restrictions that 
help us to explain variation in the types of unit the babies 
were born that is independent of outcomes. In the first 
stage, we will estimate the probability of a baby’s birth in 
NICU as a function of baby-level characteristics and IVs. 
The estimated probability of being born in an NICU will 
then be used in a second equation to estimate the effect 
of being born in an NICU on the outcomes of interest 
after controlling for a vector of observed baby-level char-
acteristics. If the IVs are correct, the 2SLS method will 
generate unbiased estimates of the place of birth on 
babies’ outcomes.
In general, a variable is considered to be an IV, if it 
is (1) associated with the type of unit at birth (NICU vs 
LNU), (2) does not have direct effect on the outcome 
(say mortality) and (3) is independent of unmeasured 
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Figure 3 Diagram of a valid instrumental variable (IV). NICU, 
neonatal intensive care unit.
Table 1 Reference cost for neonatal critical care—year 2017/2018—NHS England14
HRG codes Types of care National average unit cost (2017–2018)
XA01Z Neonatal critical care, intensive care £1445
XA02Z Neonatal critical care, high dependency 
care
£925
XA03Z Neonatal critical care, special care, carer 
not resident alongside baby
£605
XA04Z Neonatal critical care, special care, carer 
resident at cot side and caring for baby
£435
XA05Z Neonatal critical care, normal care £441
XA06Z Neonatal critical care, transportation £1159
HRG, Healthcare Resource Group; NHS, National Health Service.
confounders (UCs) but may be related to the measured 
confounders (MCs).28 29 The assumed relation of (IV) 
with outcome (4), type of unit at birth (NICU vs LNU), 
UCs and MCs can be described by the graph in figure 3.30
A potential IV, used in previous studies in the USA,26 30 
is the difference of the distances of the mother residential 
postal code to the nearest NICU and LNU postal codes 
(excess distance). This has the potential to be an appro-
priate IV because of:
(1) Association with delivery in NICUs (refers to the 
arrow from IV to NICU in figure 3). Previous studies 
suggest that a high-risk mother is more likely to deliver in 
NICU if she is living close to an NICU hospital.26
(2) No direct effect on outcomes (refers to the crossed 
line from IV to outcome in figure 3). The assumption that 
the difference in travel times to either facility should not 
directly affect the outcomes except through the route of 
whether the baby is born in an NICU hospital,29 (3) inde-
pendence of unmeasured confounding factors (refers 
to the crossed line from IV to UC in figure 3). This is 
based on the assumption that mothers do not choose 
where to live based on distance to a high-level NICU, 
since preterm delivery is usually not expected before 
pregnancy. However, because hospitals with NICUs tend 
to locate in select areas (ie, cities), mothers who live here 
may be different from those who do not, in terms of socio-
economic characteristics. We attempt to address this issue 
by controlling for mothers’ occupation and deprivation.
Analysing healthcare costs and cost-effectiveness 
outcomes: A cost analysis with a UK NHS perspective 
will be conducted. The cost of neonatal care received 
by preterm babies in NICU and LNU up to hospital 
discharge will be estimated. Standard care package in 
neonatal units will be costed by level of care, as catego-
rised by the six Healthcare Resource Groups (HRG) as 
listed in table 1. HRGs are defined to group the use of 
healthcare resources of clinically similar treatments for 
costing purposes, and each of them is attached a unit 
cost that gives the average cost to the NHS of providing 
defined services to NHS patients in England. Unit costs 
used in our economic evaluation will be extracted from 
the NHS Reference Costs 2017/2018.
The costs of standard care provided by NICU or LNU, 
unit costs will be multiplied by the number of days using 
different levels of care. Since the standard packages costed 
by HRG codes do not include all major clinical activities, 
we will also cost the use of selected relevant procedures. 
These will include nitric oxide, surfactant replacement, 
total parental nutrition, ultrasound scanning, blood 
transfusion and palivizumab therapy. Cost data for these 
activities will be obtained from literature reviews and 
extracted from selected hospital finance departments as 
needed. The cost of surgical procedures are included in 
the standard care package by the level of care defined by 
HRG codes and will not be costed separately. Key compo-
nents of healthcare resource use will be presented sepa-
rately from associated costs as currently recommended.
Original neonatal care information will be linked to HES 
to extend the time horizon of the economic evaluation 
to 1 year of corrected age. A comprehensive cost analysis 
using the methodology above will be conducted to iden-
tify whether patterns of service use of hospital admissions, 
outpatient visits and accident and emergency services 
differs across neonatal strategies at 1-year-follow-up.
The number of lives saved will be the health outcome 
measure that will be used in the economic evaluation. 
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Deaths occurring after discharge from the neonatal unit 
will be informed by the ONS linked. An incremental 
analysis of costs and health outcomes between NICUs 
and LNUs will be conducted and synthesised using the 
net-benefit framework. Current thresholds of willingness 
to pay as recommended by the National Institute for 
Health and Care Excellence (NICE) will be used to deter-
mine value for money.
We will follow current guidance for methods of tech-
nology appraisal to present and report the results of the 
economic analysis.31–33
Workstream 2
Adjusting for heterogeneity within the types of units 
studied: Using NNRD data and augmented with novel 
evaluation of the quality of care provided in neonatal 
units through a PhD project, other parameters such as 
associations with volume and calibre of work undertaken, 
medical and nursing staffing, and comparisons against 
national neonatal auditable standards (using variables 
such as normal temperature measured within the first 
hour of life, receipt of breast milk on discharge, parental 
consultation within the first 24 hours, parent presence 
on ward round, blood stream infections,among others), 
will be explored in workstream 2. This information, along 
with information about the population of babies which 
are cared for at their unit (but not including outcomes), 
will be used to undertake a cluster analysis. This analysis 
will provide groups of units which are similar in terms of 
their characteristics and the care they provide, irrespec-
tive of their designation. The identified variables will be 
assessed in two ways:
1. They will be incorporated into workstream 1 as con-
founding variables to analyse potential heterogeneity 
between units, and to investigate to what extent they 
help to explain this.
2. They will be used independently, in isolation and con-
junction, to investigate associations with gestation-spe-
cific outcomes.
Workstream 4
Understanding parent and clinician perspectives on deci-
sions about place of care: Observations will explore: (1) 
factors that parents think should guide decision-making 
about place of care for babies, and how this happens in 
practice, (2) clinicians’ perspectives and practices around 
decision-making about place of care, (3) the impact on 
parents and families of this decision, and subsequent 
changes in care location and (4) how parents can best be 
supported.
Periods of observation within neonatal units will be 
completed, along with interviews with both clinicians 
and parents. An experienced qualitative researcher will 
observe relevant discussions and interactions that take 
place between parents and clinicians regarding place of 
care. Observations will be guided by an observation frame-
work, developed through discussions with the project 
team and project parent panel. The observer will take 
written notes unobtrusively and will then debrief these 
either alone or with another member of the team. These 
debrief sessions will be audio recorded and transcribed.
Alongside observations, interviews will be conducted 
with parents and clinicians on their perspectives and 
experiences of decisions regarding place of care. We will 
also interview a separate group of parents about their 
retrospective experiences of having had a baby receive 
neonatal care in the past 12 months. Interview topic 
guides will be developed and piloted through discussions 
with the project team and parent advisory panel. Inter-
views will be audio recorded and transcribed verbatim.
Participants, who are willing and able to give informed 
consent, and are caring (or did care) for a baby born 
between 27 and 31 weeks gestation, will be included. 
Participation will be voluntary and it will be made clear to 
parents in particular that declining will not compromise 
the care they or their babies receive. Informed consent 
for participation will be obtained (written for formal 
interviews and verbal for observation).
We will conduct up to 40 interviews with parents and 
clinicians. Twenty interviews will be ‘retrospective’ inter-
views with parents whose babies had been discharged in 
the last 12 months. These will be selected from the 15 
operational delivery neonatal networks in England. This 
will be undertaken through an open national advertise-
ment for parents to participate, through the national 
parent charity for sick and preterm babies, BLISS. We 
will attempt to recruit a diverse sample of parents with 
babies born at different gestations between 27 and 31 
weeks, parents for whom this is a first or subsequent 
pregnancy, and parents of babies on different care path-
ways (eg, moving from LNU to NICU and vice versa). 
We will attempt to ensure diversity of participants in 
relation to maternal age, ethnicity, socioeconomic status 
and educational background. A further 20 will be ‘real-
time’ interviews with clinicians and parents caring for 
a baby currently receiving neonatal care. These will be 
conducted in two operational delivery networks, situated 
in the West and East Midlands, the two neonatal networks 
closest to the study centre, for practical reasons. For these 
interviews, we will also include clinicians of different 
ethnic backgrounds, ages and sexes.
The qualitative data will be analysed using the constant 
comparative method34 assisted by NVivo software. A 
coding scheme developed through detailed engagement 
with the data will be used to process the dataset system-
atically by assigning each section of text to a category, 
according to the category specifications. Parent panel 
members will be invited to comment on the face validity 
of the analysis of qualitative data.
dIssEMInAtIon
A. Written information materials have been developed 
for both parents and clinicians invited to participate 
in the ethnographic study.
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B. Presentation and publication: This will include pre-
sentation of research findings at national and interna-
tional conferences, and publication in peer-reviewed 
journals.
C. Development of recommendations for care of the ne-
onate born at 27–31 weeks gestation: A working group 
will be formed with BAPM and BLISS, to develop po-
sition statements and recommendations regarding the 
most appropriate place of care for babies born at this 
gestation in England. This will be led by investigators 
from the study and will incorporate nursing and med-
ical professionals with relevant expertise, and repre-
sentatives from the project’s parent advisory panel.
D. Consultation with healthcare professionals and other 
stakeholders: Framework documents and recommen-
dations will be processed through BAPM. This includes 
consultation with members and stakeholders (man-
agerial stakeholders including Commissioners, Net-
works, Trusts, Governmental/Regulatory stakeholders 
including the Department of Health, Public Health 
England, National Commissioning Board, Care Qual-
ity Commission, NICE and educational stakeholders 
including Royal Colleges and professional societies).
E. Publication and dissemination of recommendations: 
Recommendations will be published via BAPM and 
RCPCH. Further dissemination will occur via the neo-
natal CRG to inform evidence-based commissioning 
of neonatal services, and BLISS to inform written in-
formation for parents, parent counselling and support 
services.
Author affiliations
1Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK
2School of Medicine and Clinical Practice, University of Wolverhampton Faculty of 
Science and Engineering, Wolverhampton, UK
3Department of Neonatal Medicine, Imperial College London, London, UK
4Nuffield Department of Population Health, University of Oxford, Oxford, UK
5Department of Health Sciences, University of Leicester, Leicester, UK
6Parent Representative, BLISS National Charity for Babies Born Premature or Sick, 
London, UK
Contributors TP developed the idea for the project and developed the protocol 
in conjunction with EMB, and the Opti-Prem collaborating team. NM contributed 
to protocol development and provided guidance regarding NNRD data utilisation. 
TP, EMB and AQTI developed the concepts around workstream 2. TP and EMB are 
supervising AQTI’s PhD project around this workstream. BM and SES developed 
the statistical methodology for the project. OR-A contributed to the protocol 
development, the statistical methodology for workstreams 2 and 3, and the study 
design of the cost-effectiveness analysis in workstream 3. MY contributed to 
the development of the statistical methodology for workstreams 2 and 3 and 
contributed to the study design of the economic analysis of workstream 3. NA 
and AP developed the ethnographic element (workstream 4) of the project. ESD 
provided epidemiological and overall support for the protocol. KD is the lead for 
the BLISS parent panel and has provided support and counsel at all stages of the 
project thus far.
Funding This work is supported by the National Institute for Health Research, 
Health Services and Delivery Research Stream, project number 15/70/104 CRN 
accrual was approved by the NIHR for the period (1 August 2017 to 31 August 
2018).
Competing interests None declared.
Ethics approval Research ethics approval has been obtained through the national 
Integrated Research Application System (IRAS, reference number 212 304 and 
research ethics committee reference number 17/NE/0800). For workstreams 1, 2, 
3 and 5, a proportionate review was undertaken. For workstream 4, research ethics 
approval was obtained together with R&D approval from the individual Trusts at 
which the interviews and observations will be conducted.
Provenance and peer review Not commissioned; externally peer reviewed.
open access This is an open access article distributed in accordance with the 
Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits 
others to copy, redistribute, remix, transform and build upon this work for any 
purpose, provided the original work is properly cited, a link to the licence is given, 
and indication of whether changes were made. See: https:// creativecommons. org/ 
licenses/ by/ 4. 0/.
rEFErEnCEs
 1. Operational Delivery Networks. Available: https://www. england. nhs. 
uk/ ourwork/ part- rel/ odn/ [Accessed 02 Jan 2019].
 2. BAPM : Service standards for hospitals providing neonatal care (third 
edition), 2010. Available: https://www. bapm. org/ resources/ service- 
standards- hospitals- providing- neonatal- care- 3rd- edition- 2010 
[Accessed 28 Dec 2018].
 3. Department of Health. Toolkit for high quality neonatal services, 
2009. Available: https:// webarchive. nationalarchives. gov. uk/ 
20130123200735/ http:// www. dh. gov. uk/ en/ Publ icat ions ands tati stics/ 
Publications/ Publ icat ions Poli cyAn dGui dance/ DH_ 107845 [Accessed 
28 Dec 2018].
 4. British Association of Perinatal Medicine. Neonatal networks. 
Available: https://www. bapm. org/ neonatal- networks [Accessed 17 
Jun 2019].
 5. Marlow N, Bennett C, Draper ES, et al. Perinatal outcomes 
for extremely preterm babies in relation to place of birth in 
England: the EPICure 2 study. Arch Dis Child Fetal Neonatal Ed 
2014;99:F181–F188.
 6. Watson SI, Arulampalam W, Petrou S, et al. The effects of 
designation and volume of neonatal care on mortality and morbidity 
outcomes of very preterm infants in England: retrospective 
population-based cohort study. BMJ Open 2014;4:e004856.
 7. British association of perinatal medicine. optimal arrangements for 
neonatal intensive care units in the UK including guidance on their 
medical staffing. A Framework for Practice 2014.
 8. Office For National Statistics. Gestation specific infant mortality 
in England and Wales, 2013. Published 14 Oct 2015. Available: 
https://www. gov. uk/ government/ statistics/ gestation- specific- infant- 
mortality- in- england- and- wales- 2013 [Accessed 28 Dec 2018].
 9. NDAU 2014 Report. Available: https://www. imperial. ac. uk/ media/ 
imperial- college/ medicine/ dept- medicine/ infectious- diseases/ 
neonatology/ NDAU- Annual- Report- 2014. pdf [Accessed 28 Dec 
2018].
 10. National Institute For Health and Clinical Excellence : Neonatal 
specialist care: quality standard QS4. Available: https://www. nice. 
org. uk/ guidance/ qs4/ chapter/ Quality- statement- 1- Care- pathways- 
and- guidelines [Accessed 02 Jan 2019].
 11. Where to give birth: the options-NHS. Available: https://www. nhs. uk/ 
conditions/ pregnancy- and- baby/ where- can- i- give- birth/ [Accessed 
17 Jun 2019].
 12. Booking an appointment using the NHS e-referral service. Available: 
https://www. nhs. uk/ using- the- nhs/ nhs- services/ hospitals/ nhs- e- 
referral- service/ [Accessed 17 Jun 2019].
 13. Mangham LJ, Petrou S, Doyle LW, et al. The cost of preterm 
birth throughout childhood in England and Wales. Pediatrics 
2009;123:e312–27.
 14. Department of Health. Nhs reference cost, 2017. Available: https:// 
improvement. nhs. uk/ resources/ reference- costs/ [Accessed 23 Jan 
2019].
 15. Aliaga S, Boggess K, Ivester TS, et al. Influence of neonatal 
practice variation on outcomes of late preterm birth. Am J Perinatol 
2014;31:659–66.
 16. Rysavy MA, Li L, Bell EF, et al. Between-hospital variation in 
treatment and outcomes in extremely preterm infants. N Engl J Med 
2015;372:1801–11.
 17. Wong J, Shah P, Yoon E, et al. Inotrope use among extremely 
preterm infants in Canadian neonatal intensive care units: variation 
and outcomes. Am J Perinatol 2015;32:009–14.
 18. Boyle EM, Johnson S, Manktelow B, et al. Neonatal outcomes and 
delivery of care for infants born late preterm or moderately preterm: 
a prospective population-based study. Arch Dis Child Fetal Neonatal 
Ed 2015;100:F479–F485.
9Pillay T, et al. BMJ Open 2019;9:e029421. doi:10.1136/bmjopen-2019-029421
Open access
 19. Mason J. Qualitative researching. 2nd Edition. Sage Publications Ltd, 
2002.
 20. Silverman D. Qualitative research: theory, method and practice. 
Second Edition. SAGE Publications Ltd, 2004.
 21. Gale C, Morris I. On behalf of the neonatal data analysis unit (NDAU) 
steering board. the UK national neonatal research database: using 
neonatal data for research, quality improvement and more. Archives 
of Disease in Childhood - Education and Practice 2016;101:216–8.
 22. Webbe J, Brunton G, Ali S, et al. Parent, patient and clinician 
perceptions of outcomes during and following neonatal care: a 
systematic review of qualitative research. BMJ Paediatrics Open 
2018;2:e000343.
 23. Rosenbaum PR, Rubin DB. The central role of the propensity score in 
observational studies for causal effects. Biometrika 1983;70:41–55.
 24. D'Agostino RB. Propensity score methods for bias reduction in the 
comparison of a treatment to a non-randomized control group. Stat 
Med 1998;17:2265–81.
 25. Medlock S, Ravelli ACJ, Tamminga P, et al. Prediction of mortality 
in very premature infants: a systematic review of prediction models. 
PLoS One 2011;6:e23441.
 26. Lorch SA, Baiocchi M, Ahlberg CE, et al. The differential impact of 
delivery Hospital on the outcomes of premature infants. Pediatrics 
2012;130:270–8.
 27. Diamond A, Sekhon JS. Genetic matching for estimating causal 
effects: a general multivariate matching method for achieving 
balance in observational studies. The Review of Economics and 
Statistics 2013;3:932–45.
 28. Greenland S. An introduction to instrumental variables for 
epidemiologists. Int J Epidemiol 2000;29:722–9.
 29. Watson S, Arulampalam W, Petrou S, et al. The effect of health care 
expenditure on patient outcomes: evidence from English neonatal 
care. Health Econ 2017;26:e274–84.
 30. Yang F, Lorch SA, Small DS. Estimation of causal effects using 
instrumental variables with nonignorable missing covariates: 
application to effect of type of delivery NICU on premature infants. 
Ann Appl Stat 2014;8:48–73.
 31. Sekhon JS, Grieve RD. A matching method for improving 
covariate balance in cost-effectiveness analyses. Health Econ 
2012;21:695–714.
 32. Kreif N, Grieve R, Sadique MZ. Statistical methods for cost-
effectiveness analyses that use observational data: a critical appraisal 
tool and review of current practice. Health Econ 2013;22:486–500.
 33. Briggs AH, O'Brien BJ, Blackhouse G. Thinking outside the 
box: recent advances in the analysis and presentation of 
uncertainty in cost-effectiveness studies. Annu Rev Public Health 
2002;23:377–401.
 34. Glaser BG. Discovery of Grounded theory: strategies for qualitative 
research. 2Ed. Aldine Transaction, 2000.
